Deep learning-assisted interactive contouring of lung cancer: Impact on contouring time and consistency.

Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
PMID:

Abstract

BACKGROUND AND PURPOSE: To evaluate the impact of a deep learning (DL)-assisted interactive contouring tool on inter-observer variability and the time taken to complete tumour contouring.

Authors

  • Michael J Trimpl
    Mirada Medical Ltd, Oxford, UK.
  • Sorcha Campbell
    Edinburgh Cancer Centre, Western General Hospital, Edinburgh, UK. Electronic address: sorcha.campbell@nhslothian.scot.nhs.uk.
  • Niki Panakis
    Oxford University Hospitals NHS Foundation Trust, UK. Electronic address: niki.panakis@ouh.nhs.uk.
  • Daniel Ajzensztejn
    Oxford University Hospitals NHS Foundation Trust, UK. Electronic address: daniel.ajzensztejn@ouh.nhs.uk.
  • Emma Burke
    Oxford University Hospitals NHS Foundation Trust, UK. Electronic address: emma.burke1@ouh.nhs.uk.
  • Shawn Ellis
    Oxford University Hospitals NHS Foundation Trust, UK. Electronic address: shawn.ellis@ouh.nhs.uk.
  • Philippa Johnstone
    Peter MacCallum Cancer Centre, Melbourne, Australia. Electronic address: philippa.johnstone@petermac.org.
  • Emma Doyle
    Edinburgh Cancer Centre, Western General Hospital, Edinburgh, UK. Electronic address: emma.doyle@nhs.scot.
  • Rebecca Towers
    Mirada Medical Ltd, Oxford, UK. Electronic address: rebeccajtowers@yahoo.co.uk.
  • Geoffrey Higgins
    Department of Oncology, University of Oxford, Oxford, UK. Electronic address: geoffrey.higgins@oncology.ox.ac.uk.
  • Claire Bernard
    Le Centre Hospitalier Universitaire de Liege, BE. Electronic address: c.bernard@chuliege.be.
  • Roland Hustinx
    Nuclear Medicine Department, Centre Hospitalier Universitaire de Liège, Liège, Belgium.
  • Katherine A Vallis
    Oxford Institute for Radiation Oncology, University of Oxford, Oxford, UK.
  • Eleanor P J Stride
    Institute of Biomedical Engineering, Department of Engineering Science, University of Oxford, Oxford, UK.
  • Mark J Gooding
    2 Mirada Medical Ltd, Oxford, UK.